214 related articles for article (PubMed ID: 30300018)
1. Neoadjuvant chemotherapy plus radiation versus chemotherapy plus regional hyperthermia in high-grade soft tissue sarcomas: a retrospective comparison.
Zschaeck S; Wust P; Melcher I; Nadobny J; Rau D; Striefler J; Pahl S; Flörcken A; Kunitz A; Ghadjar P
Int J Hyperthermia; 2018; 35(1):1-9. PubMed ID: 30300018
[TBL] [Abstract][Full Text] [Related]
2. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
Issels RD; Lindner LH; Verweij J; Wessalowski R; Reichardt P; Wust P; Ghadjar P; Hohenberger P; Angele M; Salat C; Vujaskovic Z; Daugaard S; Mella O; Mansmann U; Dürr HR; Knösel T; Abdel-Rahman S; Schmidt M; Hiddemann W; Jauch KW; Belka C; Gronchi A;
JAMA Oncol; 2018 Apr; 4(4):483-492. PubMed ID: 29450452
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control.
Willner A; Agaimy A; Fechner K; Ott O; Denz A; Weissmann T; Meidenbauer N; Höfler D; Gaipl U; Frey B; Schmidt M; Haller F; Horch R; Hartmann A; Grützmann R; Fietkau R; Semrau S
Int J Hyperthermia; 2023; 40(1):2248424. PubMed ID: 37611915
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
[TBL] [Abstract][Full Text] [Related]
5. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D
Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656
[TBL] [Abstract][Full Text] [Related]
6. Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).
Stahl R; Wang T; Lindner LH; Abdel-Rahman S; Santl M; Reiser MF; Issels RD
Int J Hyperthermia; 2009 Jun; 25(4):289-98. PubMed ID: 19670096
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide.
Palassini E; Ferrari S; Verderio P; De Paoli A; Martin Broto J; Quagliuolo V; Comandone A; Sangalli C; Palmerini E; Lopez-Pousa A; De Sanctis R; Bottelli S; Libertini M; Picci P; Casali PG; Gronchi A
J Clin Oncol; 2015 Nov; 33(31):3628-34. PubMed ID: 26351345
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.
DeLaney TF; Spiro IJ; Suit HD; Gebhardt MC; Hornicek FJ; Mankin HJ; Rosenberg AL; Rosenthal DI; Miryousefi F; Ancukiewicz M; Harmon DC
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1117-27. PubMed ID: 12829150
[TBL] [Abstract][Full Text] [Related]
9. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Issels RD; Lindner LH; Verweij J; Wust P; Reichardt P; Schem BC; Abdel-Rahman S; Daugaard S; Salat C; Wendtner CM; Vujaskovic Z; Wessalowski R; Jauch KW; Dürr HR; Ploner F; Baur-Melnyk A; Mansmann U; Hiddemann W; Blay JY; Hohenberger P; ;
Lancet Oncol; 2010 Jun; 11(6):561-70. PubMed ID: 20434400
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.
Kraybill WG; Harris J; Spiro IJ; Ettinger DS; DeLaney TF; Blum RH; Lucas DR; Harmon DC; Letson GD; Eisenberg B
Cancer; 2010 Oct; 116(19):4613-21. PubMed ID: 20572040
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study.
Issels RD; Prenninger SW; Nagele A; Boehm E; Sauer H; Jauch KW; Denecke H; Berger H; Peter K; Wilmanns W
J Clin Oncol; 1990 Nov; 8(11):1818-29. PubMed ID: 2121910
[TBL] [Abstract][Full Text] [Related]
12. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.
Issels RD; Bosse D; Abdel-Rahman S; Starck M; Panzer M; Jauch KW; Stiegler H; Berger H; Sauer H; Peter K
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S233-7. PubMed ID: 8453705
[TBL] [Abstract][Full Text] [Related]
13. Effect of concurrent chemotherapy and hyperthermia on outcome of preoperative radiotherapy of high-risk soft tissue sarcomas.
Eckert F; Gani C; Kluba T; Mayer F; Kopp HG; Zips D; Bamberg M; Müller AC
Strahlenther Onkol; 2013 Jun; 189(6):482-5. PubMed ID: 23604183
[TBL] [Abstract][Full Text] [Related]
14. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors.
Wessalowski R; Schneider DT; Mils O; Hannen M; Calaminus G; Engelbrecht V; Pape H; Willers R; Engert J; Harms D; Göbel U
Klin Padiatr; 2003; 215(6):303-9. PubMed ID: 14677093
[TBL] [Abstract][Full Text] [Related]
15. Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
Wendtner CM; Abdel-Rahman S; Krych M; Baumert J; Lindner LH; Baur A; Hiddemann W; Issels RD
J Clin Oncol; 2002 Jul; 20(14):3156-64. PubMed ID: 12118030
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.
Wendtner C; Abdel-Rahman S; Baumert J; Falk MH; Krych M; Santl M; Hiddemann W; Issels RD
Eur J Cancer; 2001 Sep; 37(13):1609-16. PubMed ID: 11527685
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome.
Willner A; Fechner K; Agaimy A; Haller F; Eckstein M; Ott OJ; Putz F; Gaipl US; Kersting S; Meidenbauer N; Grützmann R; Fietkau R; Semrau S
Strahlenther Onkol; 2021 Dec; 197(12):1063-1071. PubMed ID: 34735576
[TBL] [Abstract][Full Text] [Related]
18. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
[TBL] [Abstract][Full Text] [Related]
19. Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS).
Schlemmer M; Wendtner CM; Lindner L; Abdel-Rahman S; Hiddemann W; Issels RD
Int J Hyperthermia; 2010; 26(2):127-35. PubMed ID: 20146567
[TBL] [Abstract][Full Text] [Related]
20. Effective local control of advanced soft tissue sarcoma with neoadjuvant chemoradiotherapy and surgery: A single institutional experience.
Stubbe F; Agaimy A; Ott O; Lettmaier S; Vassos N; Croner R; Hohenberger W; Fietkau R; Semrau S
Cancer Radiother; 2016 Feb; 20(1):6-13. PubMed ID: 26700874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
